CAR-T ICU 2019 | How could CAR-T affect transplantation in R/R lymphomas?
Robin Sanderson
• 10 Jul 2019
Robin Sanderson, MBBS, PhD, King’s College Hospital NHS Foundation Trust, London, UK, discusses the current use of CAR T-cell therapy in relapsed/refractory lymphoma and whether this will have an impact on the practice of stem cell transplantation. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.
